David Gaiero
Director Financiero/CFO en CYTEIR THERAPEUTICS, INC. .
Fortuna: 308 197 $ al 31/03/2024
Cargos activos de David Gaiero
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Director Financiero/CFO | 01/12/2020 | - |
| Treasurer | 16/03/2022 | - | |
| IMUNON, INC. | Comptroller/Controller/Auditor | 01/06/2024 | - |
| Director Financiero/CFO | 01/06/2024 | - | |
| Monomoy Advisors LLC | Corporate Officer/Principal | - | - |
Historial de carrera de David Gaiero
Antiguos cargos conocidos de David Gaiero.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| WAVE LIFE SCIENCES LTD. | Comptroller/Controller/Auditor | 01/07/2017 | 04/12/2020 |
| Director Financiero/CFO | 09/01/2020 | 04/12/2020 | |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Comptroller/Controller/Auditor | 01/01/2015 | 01/01/2017 |
Formación de David Gaiero.
| University of Massachusetts | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Singapur | 2 |
Operativa
| Comptroller/Controller/Auditor | 3 |
| Director of Finance/CFO | 3 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| IMUNON, INC. | Health Technology |
| WAVE LIFE SCIENCES LTD. | Health Technology |
| Empresas privadas | 3 |
|---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
| Monomoy Advisors LLC |
- Bolsa de valores
- Insiders
- David Gaiero
- Experiencia
